Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 105 entries
Sorted by: Best Match Show Resources per page
Physical Inactivity as a Missing Link in Understanding the Progression of Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine

Troosters T, Demeyer H.
PMID: 26230227
Am J Respir Crit Care Med. 2015 Aug 01;192(3):267-9. doi: 10.1164/rccm.201506-1123ED.

No abstract available.

Cite
Troosters T, Demeyer H. Physical Inactivity as a Missing Link in Understanding the Progression of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015;192(3):267-9doi: 10.1164/rccm.201506-1123ED.
Troosters, T., & Demeyer, H. (2015). Physical Inactivity as a Missing Link in Understanding the Progression of Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine, 192(3), 267-9. https://doi.org/10.1164/rccm.201506-1123ED
Troosters, Thierry, and Demeyer, Heleen. "Physical Inactivity as a Missing Link in Understanding the Progression of Chronic Obstructive Pulmonary Disease." American journal of respiratory and critical care medicine vol. 192,3 (2015): 267-9. doi: https://doi.org/10.1164/rccm.201506-1123ED
Troosters T, Demeyer H. Physical Inactivity as a Missing Link in Understanding the Progression of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015 Aug 01;192(3):267-9. doi: 10.1164/rccm.201506-1123ED. PMID: 26230227.
Copy Download .nbib Format: NLM
The natural history of COPD: confirming and going beyond Fletcher and Peto.

The European respiratory journal

Miller A, Raskin JM.
PMID: 25082904
Eur Respir J. 2014 Aug;44(2):280-3. doi: 10.1183/09031936.00079514.

No abstract available.

Cite
Miller A, Raskin JM. The natural history of COPD: confirming and going beyond Fletcher and Peto. Eur Respir J. 2014;44(2):280-3doi: 10.1183/09031936.00079514.
Miller, A., & Raskin, J. M. (2014). The natural history of COPD: confirming and going beyond Fletcher and Peto. The European respiratory journal, 44(2), 280-3. https://doi.org/10.1183/09031936.00079514
Miller, Albert, and Raskin, Jonathan M. "The natural history of COPD: confirming and going beyond Fletcher and Peto." The European respiratory journal vol. 44,2 (2014): 280-3. doi: https://doi.org/10.1183/09031936.00079514
Miller A, Raskin JM. The natural history of COPD: confirming and going beyond Fletcher and Peto. Eur Respir J. 2014 Aug;44(2):280-3. doi: 10.1183/09031936.00079514. PMID: 25082904.
Copy Download .nbib Format: NLM
Update in Chronic Obstructive Pulmonary Disease 2015.

American journal of respiratory and critical care medicine

Marchetti N, Criner GJ.
PMID: 27174481
Am J Respir Crit Care Med. 2016 May 15;193(10):1092-100. doi: 10.1164/rccm.201602-0213UP.

No abstract available.

Cite
Marchetti N, Criner GJ. Update in Chronic Obstructive Pulmonary Disease 2015. Am J Respir Crit Care Med. 2016;193(10):1092-100doi: 10.1164/rccm.201602-0213UP.
Marchetti, N., & Criner, G. J. (2016). Update in Chronic Obstructive Pulmonary Disease 2015. American journal of respiratory and critical care medicine, 193(10), 1092-100. https://doi.org/10.1164/rccm.201602-0213UP
Marchetti, Nathaniel, and Criner, Gerard J. "Update in Chronic Obstructive Pulmonary Disease 2015." American journal of respiratory and critical care medicine vol. 193,10 (2016): 1092-100. doi: https://doi.org/10.1164/rccm.201602-0213UP
Marchetti N, Criner GJ. Update in Chronic Obstructive Pulmonary Disease 2015. Am J Respir Crit Care Med. 2016 May 15;193(10):1092-100. doi: 10.1164/rccm.201602-0213UP. PMID: 27174481.
Copy Download .nbib Format: NLM
Minimal or maximal clinically important difference: using death to define MCID.

American journal of respiratory and critical care medicine

Gupta S, Chandra D, Sciurba F.
PMID: 23767906
Am J Respir Crit Care Med. 2013 Jun 15;187(12):1391-2. doi: 10.1164/rccm.201301-0073LE.

No abstract available.

Cite
Gupta S, Chandra D, Sciurba F. Minimal or maximal clinically important difference: using death to define MCID. Am J Respir Crit Care Med. 2013;187(12):1391-2doi: 10.1164/rccm.201301-0073LE.
Gupta, S., Chandra, D., & Sciurba, F. (2013). Minimal or maximal clinically important difference: using death to define MCID. American journal of respiratory and critical care medicine, 187(12), 1391-2. https://doi.org/10.1164/rccm.201301-0073LE
Gupta, Shikha, et al. "Minimal or maximal clinically important difference: using death to define MCID." American journal of respiratory and critical care medicine vol. 187,12 (2013): 1391-2. doi: https://doi.org/10.1164/rccm.201301-0073LE
Gupta S, Chandra D, Sciurba F. Minimal or maximal clinically important difference: using death to define MCID. Am J Respir Crit Care Med. 2013 Jun 15;187(12):1391-2. doi: 10.1164/rccm.201301-0073LE. PMID: 23767906.
Copy Download .nbib Format: NLM
Airway remodeling: Systems biology approach, from bench to bedside.

Technology and health care : official journal of the European Society for Engineering and Medicine

Najafi A, Ghanei M, Jamalkandi SA.
PMID: 27315153
Technol Health Care. 2016 Nov 14;24(6):811-819. doi: 10.3233/THC-161228.

Airway Remodeling, a patho-physiologic process, is considered as a key feature of chronic airway diseases. In recent years, our understanding of the complex diseases has increased significantly by the use of combined approaches, including systems biology, which may contribute...

Cite
Najafi A, Ghanei M, Jamalkandi SA. Airway remodeling: Systems biology approach, from bench to bedside. Technol Health Care. 2016;24(6):811-819doi: 10.3233/THC-161228.
Najafi, A., Ghanei, M., & Jamalkandi, S. A. (2016). Airway remodeling: Systems biology approach, from bench to bedside. Technology and health care : official journal of the European Society for Engineering and Medicine, 24(6), 811-819. https://doi.org/10.3233/THC-161228
Najafi, Ali, et al. "Airway remodeling: Systems biology approach, from bench to bedside." Technology and health care : official journal of the European Society for Engineering and Medicine vol. 24,6 (2016): 811-819. doi: https://doi.org/10.3233/THC-161228
Najafi A, Ghanei M, Jamalkandi SA. Airway remodeling: Systems biology approach, from bench to bedside. Technol Health Care. 2016 Nov 14;24(6):811-819. doi: 10.3233/THC-161228. PMID: 27315153.
Copy Download .nbib Format: NLM
Assessment of Burden of COPD (ABC) tool: perception .

The European respiratory journal

Houben-Wilke S, Franssen FM, Kok I, Otten HJ, Wempe JP, Vercoulen JH.
PMID: 28298403
Eur Respir J. 2017 Mar 15;49(3). doi: 10.1183/13993003.02382-2016. Print 2017 Mar.

No abstract available.

Cite
Houben-Wilke S, Franssen FM, Kok I, et al. Assessment of Burden of COPD (ABC) tool: perception . Eur Respir J. 2017;49(3)doi: 10.1183/13993003.02382-2016.
Houben-Wilke, S., Franssen, F. M., Kok, I., Otten, H. J., Wempe, J. P., & Vercoulen, J. H. (2017). Assessment of Burden of COPD (ABC) tool: perception . The European respiratory journal, 49(3), . https://doi.org/10.1183/13993003.02382-2016
Houben-Wilke, Sarah, et al. "Assessment of Burden of COPD (ABC) tool: perception ." The European respiratory journal vol. 49,3 (2017). doi: https://doi.org/10.1183/13993003.02382-2016
Houben-Wilke S, Franssen FM, Kok I, Otten HJ, Wempe JP, Vercoulen JH. Assessment of Burden of COPD (ABC) tool: perception . Eur Respir J. 2017 Mar 15;49(3). doi: 10.1183/13993003.02382-2016. Print 2017 Mar. PMID: 28298403.
Copy Download .nbib Format: NLM
Experience of advanced chronic obstructive pulmonary disease: metasynthesis of qualitative research.

Journal of pain and symptom management

Disler RT, Green A, Luckett T, Newton PJ, Inglis S, Currow DC, Davidson PM.
PMID: 24780181
J Pain Symptom Manage. 2014 Dec;48(6):1182-99. doi: 10.1016/j.jpainsymman.2014.03.009. Epub 2014 Apr 26.

CONTEXT: Chronic obstructive pulmonary disease (COPD) is a life-limiting illness. Despite best available treatments, individuals continue to experience symptom burden and have high health care utilization.OBJECTIVES: To increase understanding of the experience and ongoing needs of individuals living with...

Cite
Disler RT, Green A, Luckett T, et al. Experience of advanced chronic obstructive pulmonary disease: metasynthesis of qualitative research. J Pain Symptom Manage. 2014;48(6):1182-99doi: 10.1016/j.jpainsymman.2014.03.009.
Disler, R. T., Green, A., Luckett, T., Newton, P. J., Inglis, S., Currow, D. C., & Davidson, P. M. (2014). Experience of advanced chronic obstructive pulmonary disease: metasynthesis of qualitative research. Journal of pain and symptom management, 48(6), 1182-99. https://doi.org/10.1016/j.jpainsymman.2014.03.009
Disler, Rebecca T, et al. "Experience of advanced chronic obstructive pulmonary disease: metasynthesis of qualitative research." Journal of pain and symptom management vol. 48,6 (2014): 1182-99. doi: https://doi.org/10.1016/j.jpainsymman.2014.03.009
Disler RT, Green A, Luckett T, Newton PJ, Inglis S, Currow DC, Davidson PM. Experience of advanced chronic obstructive pulmonary disease: metasynthesis of qualitative research. J Pain Symptom Manage. 2014 Dec;48(6):1182-99. doi: 10.1016/j.jpainsymman.2014.03.009. Epub 2014 Apr 26. PMID: 24780181.
Copy Download .nbib Format: NLM
How do patients with exacerbated chronic obstructive pulmonary disease experience care in the intensive care unit?.

Scandinavian journal of caring sciences

Torheim H, Kvangarsnes M.
PMID: 24313779
Scand J Caring Sci. 2014 Dec;28(4):741-8. doi: 10.1111/scs.12106. Epub 2013 Dec 09.

The aim was to gain insight into how patients with advanced chronic obstructive pulmonary disease (COPD) experience care in the acute phase. The study has a qualitative design with a phenomenological approach. The empirics consist of qualitative in-depth interviews...

Cite
Torheim H, Kvangarsnes M. How do patients with exacerbated chronic obstructive pulmonary disease experience care in the intensive care unit?. Scand J Caring Sci. 2013;28(4):741-8doi: 10.1111/scs.12106.
Torheim, H., & Kvangarsnes, M. (2014). How do patients with exacerbated chronic obstructive pulmonary disease experience care in the intensive care unit?. Scandinavian journal of caring sciences, 28(4), 741-8. https://doi.org/10.1111/scs.12106
Torheim, Henny, and Kvangarsnes, Marit. "How do patients with exacerbated chronic obstructive pulmonary disease experience care in the intensive care unit?." Scandinavian journal of caring sciences vol. 28,4 (2014): 741-8. doi: https://doi.org/10.1111/scs.12106
Torheim H, Kvangarsnes M. How do patients with exacerbated chronic obstructive pulmonary disease experience care in the intensive care unit?. Scand J Caring Sci. 2014 Dec;28(4):741-8. doi: 10.1111/scs.12106. Epub 2013 Dec 09. PMID: 24313779; PMCID: PMC4260168.
Copy Download .nbib Format: NLM
Pathology and pathophysiology of chronic obstructive pulmonary disease.

Internal medicine (Tokyo, Japan)

Nagai A.
PMID: 11993785
Intern Med. 2002 Apr;41(4):265-9. doi: 10.2169/internalmedicine.41.265.

A variety of pathological changes have been observed in the central airways, peripheral airways and lung parenchyma of patients with chronic obstructive pulmonary disease (COPD). The characteristic changes in the central airways include inflammatory cellular infiltration into the airway...

Cite
Nagai A. Pathology and pathophysiology of chronic obstructive pulmonary disease. Intern Med. 2002;41(4):265-9doi: 10.2169/internalmedicine.41.265.
Nagai, A. (2002). Pathology and pathophysiology of chronic obstructive pulmonary disease. Internal medicine (Tokyo, Japan), 41(4), 265-9. https://doi.org/10.2169/internalmedicine.41.265
Nagai, Atsushi. "Pathology and pathophysiology of chronic obstructive pulmonary disease." Internal medicine (Tokyo, Japan) vol. 41,4 (2002): 265-9. doi: https://doi.org/10.2169/internalmedicine.41.265
Nagai A. Pathology and pathophysiology of chronic obstructive pulmonary disease. Intern Med. 2002 Apr;41(4):265-9. doi: 10.2169/internalmedicine.41.265. PMID: 11993785.
Copy Download .nbib Format: NLM
Therapy for chronic obstructive pulmonary disease in the 21st century.

Drugs

Donnelly LE, Rogers DF.
PMID: 12962514
Drugs. 2003;63(19):1973-98. doi: 10.2165/00003495-200363190-00002.

Chronic obstructive pulmonary disease (COPD) is a common, smoking-related, severe respiratory condition characterised by progressive, irreversible airflow limitation. Current treatment of COPD is symptomatic, with no drugs capable of halting the relentless progression of airflow obstruction. Better understanding of...

Cite
Donnelly LE, Rogers DF. Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs. 2003;63(19):1973-98doi: 10.2165/00003495-200363190-00002.
Donnelly, L. E., & Rogers, D. F. (2003). Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs, 63(19), 1973-98. https://doi.org/10.2165/00003495-200363190-00002
Donnelly, Louise E, and Rogers, Duncan F. "Therapy for chronic obstructive pulmonary disease in the 21st century." Drugs vol. 63,19 (2003): 1973-98. doi: https://doi.org/10.2165/00003495-200363190-00002
Donnelly LE, Rogers DF. Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs. 2003;63(19):1973-98. doi: 10.2165/00003495-200363190-00002. PMID: 12962514.
Copy Download .nbib Format: NLM
Mortality in COPD: Role of comorbidities.

The European respiratory journal

Sin DD, Anthonisen NR, Soriano JB, Agusti AG.
PMID: 17138679
Eur Respir J. 2006 Dec;28(6):1245-57. doi: 10.1183/09031936.00133805.

Chronic obstructive pulmonary disease (COPD) represents an increasing burden throughout the world. COPD-related mortality is probably underestimated because of the difficulties associated with identifying the precise cause of death. Respiratory failure is considered the major cause of death in...

Cite
Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: Role of comorbidities. Eur Respir J. 2006;28(6):1245-57doi: 10.1183/09031936.00133805.
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006). Mortality in COPD: Role of comorbidities. The European respiratory journal, 28(6), 1245-57. https://doi.org/10.1183/09031936.00133805
Sin, D D, et al. "Mortality in COPD: Role of comorbidities." The European respiratory journal vol. 28,6 (2006): 1245-57. doi: https://doi.org/10.1183/09031936.00133805
Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of comorbidities. Eur Respir J. 2006 Dec;28(6):1245-57. doi: 10.1183/09031936.00133805. PMID: 17138679.
Copy Download .nbib Format: NLM
COPD as a systemic disease.

COPD

Agusti A, Soriano JB.
PMID: 18415812
COPD. 2008 Apr;5(2):133-8. doi: 10.1080/15412550801941349.

Chronic obstructive pulmonary disease (COPD) represents an important and increasing burden throughout the world. Classically, COPD has been considered a respiratory condition only, mainly caused by tobacco smoking. However, COPD has important manifestations beyond the lungs, the so-called systemic...

Cite
Agusti A, Soriano JB. COPD as a systemic disease. COPD. 2008;5(2):133-8doi: 10.1080/15412550801941349.
Agusti, A., & Soriano, J. B. (2008). COPD as a systemic disease. COPD, 5(2), 133-8. https://doi.org/10.1080/15412550801941349
Agusti, Alvar, and Soriano, Joan B. "COPD as a systemic disease." COPD vol. 5,2 (2008): 133-8. doi: https://doi.org/10.1080/15412550801941349
Agusti A, Soriano JB. COPD as a systemic disease. COPD. 2008 Apr;5(2):133-8. doi: 10.1080/15412550801941349. PMID: 18415812.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 105 entries